Tivity Health Inc (NASDAQ:TVTY) has earned a consensus recommendation of “Buy” from the twelve analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $34.00.

A number of research firms have recently weighed in on TVTY. Jefferies Financial Group lowered their target price on Tivity Health to $29.00 and set a “buy” rating for the company in a research note on Wednesday, February 20th. Piper Jaffray Companies lowered their target price on Tivity Health to $29.00 and set an “overweight” rating for the company in a research note on Wednesday, February 20th. Cantor Fitzgerald boosted their target price on Tivity Health from $40.00 to $45.00 and gave the company an “overweight” rating in a research note on Thursday, May 9th. Zacks Investment Research raised Tivity Health from a “sell” rating to a “hold” rating in a research report on Thursday, February 21st. Finally, BidaskClub raised Tivity Health from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 8th.

Shares of NASDAQ TVTY traded down $0.11 during midday trading on Thursday, reaching $18.04. The company had a trading volume of 956,552 shares, compared to its average volume of 1,273,228. Tivity Health has a one year low of $16.25 and a one year high of $41.46. The company has a current ratio of 0.86, a quick ratio of 0.71 and a debt-to-equity ratio of 2.13. The firm has a market cap of $865.76 million, a PE ratio of 7.68, a price-to-earnings-growth ratio of 0.78 and a beta of 1.10.

Tivity Health (NASDAQ:TVTY) last released its earnings results on Wednesday, May 8th. The company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.01. Tivity Health had a return on equity of 26.02% and a net margin of 12.18%. The company had revenue of $214.10 million during the quarter, compared to analyst estimates of $200.39 million. During the same quarter in the previous year, the company posted $0.49 EPS. Tivity Health’s revenue for the quarter was up 42.8% on a year-over-year basis. As a group, equities research analysts forecast that Tivity Health will post 2.35 earnings per share for the current fiscal year.

In other news, Director Bradley S. Karro bought 2,900 shares of Tivity Health stock in a transaction on Friday, March 22nd. The shares were purchased at an average price of $16.54 per share, for a total transaction of $47,966.00. Following the acquisition, the director now owns 24,696 shares of the company’s stock, valued at $408,471.84. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Sara Finley bought 2,000 shares of Tivity Health stock in a transaction on Wednesday, March 20th. The shares were purchased at an average price of $17.25 per share, for a total transaction of $34,500.00. The disclosure for this purchase can be found here. Corporate insiders own 1.64% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. Handelsinvest Investeringsforvaltning purchased a new position in shares of Tivity Health during the 4th quarter worth approximately $1,711,000. Rhumbline Advisers grew its holdings in shares of Tivity Health by 23.6% during the 4th quarter. Rhumbline Advisers now owns 114,174 shares of the company’s stock worth $2,833,000 after acquiring an additional 21,834 shares during the period. Renaissance Technologies LLC grew its holdings in shares of Tivity Health by 1,148.0% during the 3rd quarter. Renaissance Technologies LLC now owns 69,889 shares of the company’s stock worth $2,247,000 after acquiring an additional 64,289 shares during the period. Elk Creek Partners LLC purchased a new position in shares of Tivity Health during the 4th quarter worth approximately $5,935,000. Finally, Virtu Financial LLC purchased a new stake in shares of Tivity Health in the 4th quarter worth approximately $410,000.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Featured Story: Hedge Funds

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.